Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil McNaughton

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Journal of Affective Disorders|December 7, 2024
Frontal localisation of a theory-based anxiety disorder biomarker - Goal conflict specific rhythmicityShabah M Shadli, Bruce R Russell, Veema Lodhia, et al.
Journal of Neuroscience Methods|September 2, 2017
Removing eye blink artefacts from EEG-A single-channel physiology-based methodShenghuan Zhang, Julia McIntosh, Shabah M Shadli, et al.
Journal of Psychopharmacology (Oxford, England)|September 19, 2019
Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders: Exploratory double-blind psychoactive-controlled replication studyPaul Glue, Shona Neehoff, Amandine Sabadel, et al.
Journal of Psychopharmacology (Oxford, England)|September 2, 2024
Is lack of goal-conflict-specific rhythmicity a biomarker for treatment resistance in generalised anxiety but not social anxiety or major depression?Shabah M Shadli, Carina J Donegan, Muhammad Ss Bin Mohd Fahmi, et al.
Journal of Psychopharmacology (Oxford, England)|April 27, 2017
Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disordersPaul Glue, Natalie J Medlicott, Sarah Harland, et al.
Scientific Reports|October 6, 2021
Right frontal anxiolytic-sensitive EEG 'theta' rhythm in the stop-signal task is a theory-based anxiety disorder biomarkerShabah M Shadli, Lynne C Ando, Julia McIntosh, et al.
Journal of Psychopharmacology (Oxford, England)|November 28, 2024
Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover studyBen Beaglehole, Paul Glue, Shona Neehoff, et al.
Journal of Psychopharmacology (Oxford, England)|June 5, 2025
Six weeks open-label oral ketamine for patients with treatment-resistant depression, post-traumatic stress disorder, or obsessive-compulsive disorderBen Beaglehole, Paul Glue, Shona Neehoff, et al.
Bjpsych Open|October 1, 2025
Ketamine for treatment-resistant post-traumatic stress disorder: double-blind active-controlled randomised crossover studyBen Beaglehole, Paul Glue, Shona Neehoff, et al.
Neuroscience and Biobehavioral Reviews|February 1, 2015
Anterior thalamic nuclei lesions and recovery of function: Relevance to cognitive thalamusJohn C Dalrymple-Alford, Bruce Harland, Elena A Loukavenko, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Journal of Affective Disorders|December 7, 2024
Frontal localisation of a theory-based anxiety disorder biomarker - Goal conflict specific rhythmicityShabah M Shadli, Bruce R Russell, Veema Lodhia, et al.
Journal of Neuroscience Methods|September 2, 2017
Removing eye blink artefacts from EEG-A single-channel physiology-based methodShenghuan Zhang, Julia McIntosh, Shabah M Shadli, et al.
Journal of Psychopharmacology (Oxford, England)|September 19, 2019
Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders: Exploratory double-blind psychoactive-controlled replication studyPaul Glue, Shona Neehoff, Amandine Sabadel, et al.
Journal of Psychopharmacology (Oxford, England)|September 2, 2024
Is lack of goal-conflict-specific rhythmicity a biomarker for treatment resistance in generalised anxiety but not social anxiety or major depression?Shabah M Shadli, Carina J Donegan, Muhammad Ss Bin Mohd Fahmi, et al.
Journal of Psychopharmacology (Oxford, England)|April 27, 2017
Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disordersPaul Glue, Natalie J Medlicott, Sarah Harland, et al.
Scientific Reports|October 6, 2021
Right frontal anxiolytic-sensitive EEG 'theta' rhythm in the stop-signal task is a theory-based anxiety disorder biomarkerShabah M Shadli, Lynne C Ando, Julia McIntosh, et al.
Journal of Psychopharmacology (Oxford, England)|November 28, 2024
Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover studyBen Beaglehole, Paul Glue, Shona Neehoff, et al.
Journal of Psychopharmacology (Oxford, England)|June 5, 2025
Six weeks open-label oral ketamine for patients with treatment-resistant depression, post-traumatic stress disorder, or obsessive-compulsive disorderBen Beaglehole, Paul Glue, Shona Neehoff, et al.
Bjpsych Open|October 1, 2025
Ketamine for treatment-resistant post-traumatic stress disorder: double-blind active-controlled randomised crossover studyBen Beaglehole, Paul Glue, Shona Neehoff, et al.
Neuroscience and Biobehavioral Reviews|February 1, 2015
Anterior thalamic nuclei lesions and recovery of function: Relevance to cognitive thalamusJohn C Dalrymple-Alford, Bruce Harland, Elena A Loukavenko, et al.
Pageof 8